DISCLOSEDQuarterly
Mukul Agrawal
Kilitch Drugs India Ltd · NSE
4,70,000 sh
Filed 8 Jul 2026NSE shareholding patternview source
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Sep 2025 63.8%, Dec 2025 63.8%, Mar 2026 63.8%.
FII
— 0.0pp
FII holding by quarter: Sep 2025 0.0%, Dec 2025 0.0%, Mar 2026 0.0%.
DII
— 0.0pp
DII holding by quarter: Sep 2025 0.0%, Dec 2025 0.0%, Mar 2026 0.0%.
Mukul Agrawal
Kilitch Drugs India Ltd · NSE
4,70,000 sh
Mukul Agrawal
Kilitch Drugs India Ltd · NSE
4,70,000 sh
Mukul Agrawal
Kilitch Drugs India Ltd · NSE
2,35,000 sh
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
19 announcements on record for this company.
MF
— 0.0pp
MF holding by quarter: Sep 2025 0.0%, Dec 2025 0.0%, Mar 2026 0.0%.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Sep 2025 63.8%, Dec 2025 63.8%, Mar 2026 63.8%.
FII
— 0.0pp
FII holding by quarter: Sep 2025 0.0%, Dec 2025 0.0%, Mar 2026 0.0%.
DII
— 0.0pp
DII holding by quarter: Sep 2025 0.0%, Dec 2025 0.0%, Mar 2026 0.0%.
MF
— 0.0pp
MF holding by quarter: Sep 2025 0.0%, Dec 2025 0.0%, Mar 2026 0.0%.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
19 announcements on record for this company.